Ann: Letter to Shareholders, page-3

  1. 693 Posts.
    lightbulb Created with Sketch. 130
    Dear Shareholders I am pleased to report that Biotron is in the final stage of three Phase 2 clinical trials for HIV‐1 and COVID‐19. This is a pivotal time for the Company as it completes data collection and analyses of samples and information collected during the trials ahead of the release of headline data in the coming weeks.

    I like the wording "Release of headline data"
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
0.2¢
Change
0.000(0.00%)
Mkt cap ! $2.654M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
45 30194319 0.2¢
 

Sellers (Offers)

Price($) Vol. No.
0.3¢ 16274992 22
View Market Depth
Last trade - 16.21pm 15/07/2025 (20 minute delay) ?
BIT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.